Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Cardiology Homepage

FDA gives thumbs-up to Genetesis MCG cardiac imaging system Measures magnetic fields produced by heart's electrical activity

Apple study suggests wearable technology may be useful in detecting atrial fibrillation May assist in stroke and hospitalization prevention

FDA gives green light for smallest, slimmest 3T CRM devices Extended battery lives, greater diagnostic and therapeutic capabilities

Echocardiogram should play role in patient selection for transcatheter mitral valve repair, says study New study highlighted at ACC

Level Ex releases interventional cardiac video game, Cardio Ex Over 35 levels that test cognitive, spatial reasoning and decision-making skills

Siemens to unveil its SOMATOM go.Top Cardiovascular Edition CT at ACC 19 Ideal for the cardiovascular outpatient setting

FDA approves Sonavex's EchoSure system Monitors blood flow following surgical procedures

Siemens unveils Artis icono biplane angio system at ECR Enables diagnostics and treatment to take place in same lab, improved 2D and 3D capabilities

Personalized cardiac test could eliminate unnecessary catheterizations Examines flow of blood with AI and CT

Noninvasive approach for imaging carotid artery shows promise Enables risk assessment for cardiovascular disease

Heart disease second leading cause of death for cancer survivors

by John W. Mitchell , Senior Correspondent
In a cruel twist, cancer and its treatment mean that survivors often must contend with the risk of cardiac disease.

This, according to a presentation titled "The Role of Nuclear Cardiology in Center of Excellence" Tuesday at the annual SNMMI meeting convened in Denver this week.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510

“Sometimes it seems cancer and heart disease coexist in a race to kill cancer survivors,” Dr. Ronald Schwartz, director of Nuclear Cardiology and Cardiac PET/CT at the Paul N. Yu Heart Center and Science Park at the University of Rochester Medical Center, told HCB News.

According to 2012 data from the National Health and Nutrition Examination Surveys presented by Schwartz, 51 percent of initial cancer survivors eventually die from their cancer. The second leading cause of death among the group – 33 percent – died from heart disease.

Schwartz was one of three panel members who made the presentation. The other two members were Italian nuclear cardiologist Wanda Acampa, M.D., Ph.D. and Prem Soman, M.D., Ph.D., a Pittsburg area nuclear cardiologist. The three said that heart failure is a threat to patients who have a comorbid heart disease when they get cancer. Also, their heart disease can become onset, related to their oncology treatments. They advocated that a strong nuclear cardiac program to enable cardiologists to study and follow cancer patients is a vital component of their survivability.

According to a 2016 paper published in the Journal Circulation, cardiovascular disease (CVD) and cancer are the two leading causes of death worldwide. The researchers found that the two diseases “possess various similarities and possible interactions” that contribute to emerging evidence of a shared biology.

The authors concluded that: “Therapeutic advances, despite improving longevity, have increased the overlap between these diseases, with millions of cancer survivors now at risk of developing CVD.”

The main takeaway points from the SNMMI presentation – which was highly technical – were:

- Cardio-oncology must be part of comprehensive cancer care and be patient-centered.
- Nuclear cardiology studies can effectively detect cardiotoxicity, prevent congestive heart failure, and evaluate myocardial perfusion and ischemic risk in patients with cancer.
- Radionuclide studies may provide additional information to manage specific cancer-related issues, including infiltrative disease (amyloid, sarcoid), and infections.
- PET/CT has provided insights into the pathophysiological role of coronary microvascular disease among cancer survivors.
- Assessment of coronary microvascular function has gained increasing popularity in the clinical setting, both for diagnostic purposes and for the evaluation of therapeutic interventions.
- The coronary microvasculature cannot be managed in vivo. But different invasive and noninvasive techniques can be used to assess functional parameters.

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.